The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells

Journal of Virology

Volumn 80, Issue 7, 2006, Pages 3180-3188

  Chu, Victor C ^a   McElroy, Lisa J ^a   Chu, Vicky ^a   Bauman, Beverley E ^a   Whittaker, Gary R ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b Animal Health Diagnostic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; CHICK EMBRYO; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CORONAVIRUS; EMBRYO; ENDOCYTOSIS; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST CELL; IMMUNOFLUORESCENCE MICROSCOPY; LOW TEMPERATURE; NONHUMAN; PH; PRIORITY JOURNAL; VIRION; VIRUS ACTIVATION; VIRUS CELL INTERACTION;

AMMONIUM CHLORIDE; ANIMALS; CELL LINE; CHICK EMBRYO; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYDROGEN-ION CONCENTRATION; INFECTIOUS BRONCHITIS VIRUS; INFLUENZA A VIRUS; MEMBRANE FUSION; MICROSCOPY, FLUORESCENCE; PROTEIN CONFORMATION; SENDAI VIRUS; TEMPERATURE; TIME FACTORS; VIRION;

ANIMALIA; AVES; AVIAN INFECTIOUS BRONCHITIS VIRUS; CORONAVIRUS;

EID: 33645229326     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.7.3180-3188.2006     Document Type: Article

References (57)

1. Beaudette, F. R., and C. R. Hudson. 1937. Cultivation of the virus of infectious bronchitis. J. Am. Vet. Med. Assoc. 90:51-60.
2. Bosch, B. J., B. E. Martina, R. Van Der Zee, J. Lepault, B. J. Haijema, C. Versluis, A. J. Heck, R. De Groot, A. D. Osterhaus, and P. J. Rottier. 2004. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. USA 101:8455-8460.
3. Bosch, B. J., R. van der Zee, C. A. de Haan, and P. J. Rottier. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77:8801-8811.
4. Boulay, F., R. W. Doms, I. Wilson, and A. Helenius. 1987. The influenza hemagglutinin precursor as an acid-sensitive probe of the biosynthetic pathway. EMBO J. 6:2643-2650.
5. Cavanagh, D. 2005. Coronaviridae: a review of coronaviruses and toroviruses, p. 1-54. In A. Schmidt, M. H. Wolff, and O. Weber (ed.), Coronaviruses with special emphasis on first insights concerning SARS. Birkhauser Verlag, Basel, Switzerland.
6. Cavanagh, D. 1995. The coronavirus surface glycoprotein, p. 73-113. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
7. Cavanagh, D., and P. J. Davis. 1986. Coronavirus IBV: removal of spike glycopolypeptide S1 by urea abolishes infectivity and haemagglutination but not attachment to cells. J. Gen. Virol. 67:1443-1448.
8. Cavanagh, D., and S. A. Naqi. 2003. Infectious bronchitis, p. 101-119. In S. M. Saif (ed.), Diseases of poultry. Iowa State Press, Ames, Iowa.
9. Chambers, P., C. R. Pringle, and A. J. Easton. 1990. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:3075-3080.
10. Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684.
11. Colman, P. M., and M. C. Lawrence. 2003. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell. Biol. 4:309-319.
12. Earp, L. J., S. E. Delos, R. C. Netter, P. Bates, and J. M. White. 2003. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH. J. Virol. 77:3058-3066.
13. Earp, L. J., S. E. Delos, H. E. Park, and J. M. White. 2005. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285:25-66.
14. Eckert, D. M., and P. S. Kim. 2001. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70:777-810.
15. Fabricant, J. 1951. Studies on the diagnosis of Newcastle disease and infectious bronchitis. IV. The use of the serum neutralization test in the diagnosis of infectious bronchitis. Cornell Vet. 61:68-80.
16. Gallagher, T. M., and M. J. Buchmeier. 2001. Coronavirus spike proteins in viral entry and pathogenesis. Virology 279:371-374.
17. Gaudin, Y. 2000. Reversibility in fusion protein conformational changes. The intriguing case of rhabdovirus-induced membrane fusion. Subcell. Biochem. 34:379-408.
18. Gilbert, J. M., D. Mason, and J. M. White. 1990. Fusion of Rous sarcoma virus with host cells does not require exposure to low pH. J. Virol. 64:5106-5113.
19. Hansen, G. H., B. Delmas, L. Besnardeau, L. K. Vogel, H. Laude, H. Sjostrom, and O. Noren. 1998. The coronavirus transmissible gastroenteritis virus causes infection after receptor-mediated endocytosis and acid-dependent fusion with an intracellular compartment. J. Virol. 72:527-534.
20. Hoekstra, D., and K. Klappe. 1993. Fluorescence assays to monitor fusion of enveloped viruses. Methods Enzymol. 220:261-276.
21. Hofmann, H., and S. Pohlmann. 2004. Cellular entry of the SARS coronavirus. Trends Microbiol. 12:466-472.
22. Holmes, K. V. 2003. SARS-associated Coronavirus. N. Engl. J. Med. 348:1948-1951.
23. Holmes, K. V., and S. R. Compton. 1995. Coronavirus receptors, p. 55-71. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
24. Jiang, S., K. Lin, N. Strick, and A. R. Neurath. 1993. HIV-1 inhibition by a peptide. Nature 365:113.
25. Karaca, K., S. Naqi, and J. Gelb, Jr. 1992. Production and characterization of monoclonal antibodies to three infectious bronchitis virus serotypes. Avian Dis. 36:903-915.
26. Kliger, Y., and E. Y. Levanon. 2003. Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy. BMC Microbiol. 3:20.
27. Korte, T., and A. Herrmann. 1994. pH-dependent binding of the fluorophore bis-ANS to influenza virus reflects the conformational change of hemagglutinin. Eur. Biophys. J. 23:105-113.
28. Lai, M. M. C., and K. V. Holmes. 2001. Coronaviridae: the viruses and their replication. In D. M. Knipe and P. M. Howely (ed.), Fields virology. Lippincott Wilkins and Williams, Philadelphia, Pa.
29. Lewicki, D. N., and T. M. Gallagher. 2002. Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors. J. Biol. Chem. 277:19727-19734.
30. Li, D., and D. Cavanagh. 1992. Coronavirus IBV-induced membrane fusion occurs at near-neutral pH. Arch. Virol. 122:307-316.
31. Liu, S., G. Xiao, Y. Chen, Y. He, J. Niu, C. R. Escalante, H. Xiong, J. Farmar, A. K. Debnath, P. Tien, and S. Jiang. 2004. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363:938-947.
32. Lontok, E., E. Corse, and C. E. Machamer. 2004. Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site. J. Virol. 78:5913-5922.
33. Marsh, M., and R. Bron. 1997. SFV infection in CHO cells: cell-type specific restrictions to productive virus entry at the cell surface. J. Cell Sci. 110:95-103.
34. Matsuyama, S., and F. Taguchi. 2002. Receptor-induced conformational changes of murine coronavirus spike protein. J. Virol. 76:11819-11826.
35. Matsuyama, S., M. Ujike, S. Morikawa, M. Tashiro, and F. Taguchi. 2005. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc. Natl. Acad. Sci. USA 102:12543-12547.
36. McMartin, D. 1993. Infectious bronchitis. In J. B. McFerran and M. S. McNulty (ed.), Virus infections of birds. Elsevier, Amsterdam, The Netherlands.
37. Melikyan, G. B., R. J. Barnard, L. G. Abrahamyan, W. Mothes, and J. A. Young. 2005. Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. Proc. Natl. Acad. Sci. USA 102:8728-8733.
38. Mothes, W., A. L. Boerger, S. Narayan, J. M. Cunningham, and J. A. T. Young. 2000. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 103:679-689.
39. Ohki, S., T. D. Flanagan, and D. Hoekstra. 1998. Probe transfer with and without membrane fusion in a fluorescence fusion assay. Biochemistry 37:7496-7503.
40. Otsuki, K., K. Noro, H. Yamamoto, and M. Tsubokura. 1979. Studies on avian infectious bronchitis virus (IBV). II. Propagation of IBV in several cultured cells. Arch. Virol. 60:115-122.
41. Payne, H. R., and J. Storz. 1988. Analysis of cell fusion induced by bovine coronavirus infection. Arch. Virol. 103:27-33.
42. Pedroso de Lima, M. C., J. Ramalho-Santos, M. F. Martins, A. Pato de Carvalho, V. Bairos, and S. Nir. 1992. Kinetic modeling of Sendai virus fusion with PC-12 cells. Effect of pH and temperature on fusion and viral inactivation. Eur. J. Biochem. 205:181-186.
43. Peiris, J. S., Y. Guan, and K. Y. Yuen. 2004. Severe acute respiratory syndrome. Nat. Med. 10:S88-S97.
44. Puri, A., J. Winick, R. J. Lowy, D. Covell, O. Eidelman, A. Walter, and R. Blumenthal. 1988. Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J. Biol. Chem. 263:4749-4753.
45. Roberts, P. C., T. Kipperman, and R. W. Compans. 1999. Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line. J. Virol. 73:10447-10457.
46. Rosen, C. G., and G. Weber. 1969. Dimer formation from 1-amino-8-naphthalenesulfonate catalyzed by bovine serum albumin. A new fluorescent molecule with exceptional binding properties. Biochemistry 8:3915-3920.
47. Sieczkarski, S. B., and G. R. Whittaker. 2002. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J. Virol. 76:10455-10464.
48. Simmons, G., D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, and P. Bates. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102:11876-11881.
49. Simmons, G., J. D. Reeves, A. J. Rennekamp, S. M. Amberg, A. J. Piefer, and P. Bates. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA 101:4240-4245.
50. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
51. Sturman, L. S., C. S. Ricard, and K. V. Holmes. 1990. Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37°C correlates with virus aggregation and virus-induced cell fusion. J. Virol. 64:3042-3050.
52. Veiga, S., Y. Yuan, X. Li, N. C. Santos, G. Liu, and M. A. Castanho. 2005. Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions. Biochim. Biophys. Acta 1760:55-61.
53. Vennema, H., L. Heijnen, A. Zijderveld, M. C. Horzinek, and W. J. Spaan. 1990. Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J. Virol. 64:339-346.
54. Weismiller, D. G., L. S. Sturman, M. J. Buchmeier, J. O. Fleming, and K. V. Holmes. 1990. Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions. J. Virol. 64:3051-3055.
55. Weiss, S. R., and S. Navas-Martin. 2005. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 69:635-664.
56. Wu, M. M., M. Grabe, S. Adams, R. Y. Tsien, H. P. Moore, and T. E. Machen. 2001. Mechanisms of pH regulation in the regulated secretory pathway. J. Biol. Chem. 276:33027-33035.
57. Zelus, B. D., J. H. Schickli, D. M. Blau, S. R. Weiss, and K. V. Holmes. 2003. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37°C either by soluble murine CEACAM1 receptors or by pH 8. J. Virol. 77:830-840.